Key statistics
On Tuesday, Transmedics Group Inc (TMDX:NMQ) closed at 133.82, -14.22% below its 52-week high of 156.00, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 129.28 |
|---|---|
| High | 137.49 |
| Low | 128.00 |
| Bid | 133.00 |
| Offer | 138.43 |
| Previous close | 129.84 |
| Average volume | 535.03k |
|---|---|
| Shares outstanding | 34.17m |
| Free float | 33.16m |
| P/E (TTM) | 54.54 |
| Market cap | 4.44bn USD |
| EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
- TransMedics to Present at Upcoming March Investor Conferences
- TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
- TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
- TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
More ▼
